NATCO Pharma Limited

BSE
NATCOPHARM
Promoção
Lucratividade por seis meses: -28.87%
Rendimento de dividendos: 0.7538%

912.55 ₹

0 ₹ 0%
746.85 ₹
1592.6 ₹

Min./max. por um ano

Cronograma de promoção NATCO Pharma Limited

Os principais parâmetros

A moeda do relatório
inr
Div
0.9395
Dividendo ao
6
Indústria
Pharmaceuticals
Isin
INE987B01026
Moeda
inr
Setor
Health Care
Site

Nota

Subestimação
Nome Significado Nota
P/S 4.28 4
P/BV 2.91 6
P/E 12.27 8
Eficiência
Nome Significado Nota
ROA 22.1 7
ROE 25.88 8
ROIC 0 0
Dividendos
Nome Significado Nota
Rendimento de dividendos 0.7538 1.88
DSI 0.8571 8.57
O crescimento médio de dividendos -2.74 0
Obrigação
Nome Significado Nota
Debt/EBITDA 0.1605 10
Debt/Ratio 0.0242 10
Debt/Equity 0.1799 10
Pulso de crescimento
Nome Significado Nota
Receita, bilhão, % 110.76 10
Ebitda, % 12.83 2
EPS, % 206.73 10

Preços

Preço Min. Máx. Mudar Mudanças na indústria Mudanças no índice
Ontem 912.55 ₹ 0 ₹ 0 ₹ 0 % 0 % 0 %
Semana 863.45 ₹ 0 ₹ 0 ₹ +5.69 % 0 % 0 %
Mês 879.9 ₹ 0 ₹ 0 ₹ +3.71 % 0 % 0 %
3 meses 746.85 ₹ 824 ₹ 934.25 ₹ +22.19 % 0 % 0 %
Seis meses 1 283 ₹ 746.85 ₹ 934.25 ₹ -28.87 % 0 % 0 %
Ano 1 563.75 ₹ 746.85 ₹ 1 592.6 ₹ -41.64 % 0 % 0 %
3 anos 615.45 ₹ 522.75 ₹ 1 592.6 ₹ +48.27 % 0 % 0 %
5 anos 717.9 ₹ 522.75 ₹ 1 592.6 ₹ +27.11 % 0 % 0 %
10 anos 392.55 ₹ 392.55 ₹ 2 608.6 ₹ +232.47 % 0 % 0 %
No acumulado do ano 1 366.85 ₹ 746.85 ₹ 1 398.7 ₹ -33.24 % 0 % 0 %

A administração da empresa

Supervisor Cargo Pagamento Ano de nascimento
Mr. Rajeev Nannapaneni CEO & Vice Chairman N/A 1977 (48 anos)
Mr. S. V. V. N. Appa Rao Chief Financial Officer N/A
Dr. Donthineni Linga Rao M.D. President of Technical Affairs & Whole Time Director N/A 1952 (73 anos)
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. MD & Chairman N/A 1945 (80 anos)
Mr. Potluri Sivaramakrishna Prasad Executive VP of Corporate Engineering Services & Whole Time Director N/A 1958 (67 anos)
Mr. Chekuri Venkat Ramesh C.S. Company Secretary & Compliance Officer 3M
Dr. Pavan Ganapati Bhat Executive VP of Technical Operations & Director N/A 1967 (58 anos)
N. Sadasiva Rao Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management N/A
James Rajakumar Vice President of Marketing & Sales - Domestic N/A
Nadella Malleswara Rao VP & Head of Operations

Informações sobre a empresa

Endereço: India, Hyderabad, Natco House - Abrir no google cards, Abra os cartões yandex
Site: https://www.natcopharma.co.in

Sobre a empresa NATCO Pharma Limited

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.